Related Experiment Video
Updated: May 26, 2026

The Participant-Reported Implementation Update and Score (PRIUS): A Novel Method for Capturing Implementation-Related Data Over Time
Published on: February 19, 2021
Pharmaceutical pricing and reimbursement information (PPRI): evolution and impact of a policy network over two
Sabine Vogler1,2, Friederike Windisch1, Verena Knoll1
1Pharmacoeconomics Department, WHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement Policies, Gesundheit Österreich GmbH (GÖG/Austrian National Public Health Institute), Vienna, Austria.
Background:
In 2005, the Pharmaceutical Pricing and Reimbursement Information (PPRI) network of public authorities was established to offer a platform for information exchange among authorities responsible for pharmaceutical pricing and reimbursement. The article reviews the evolution of PPRI over its twenty years of existence and aims to identify its contributions to policymakers and the research community as well as areas for future development.
Methods:
Based on a framework of structure, process and outcome indicators, adapted from the Donabedian Model, the article examines developments regarding membership in terms of geographic and thematic scope, governance, procedures for intra-network exchange of information as well as stakeholder engagement, and outcomes in terms of scientific output and spin-off activities. The review was informed by grey and peer-reviewed literature as well as unpublished information within the PPRI network.
Results:
The PPRI network has evolved from a European group into a global network, comprising approximately 80 public authorities in pharmaceutical pricing and reimbursement from 50 countries. Its thematic focus remains pricing and reimbursement policies, and additionally, the PPRI network addressed several related topics. In 2018, a sub-group on medical devices (PPRI MD) was established. PPRI mainly serves its members by facilitating informed discussion at face-to-face and online meetings, and through internal queries on timely and policy-related topics. PPRI-sourced data has been published, including country information such as PPRI Pharma Profiles and Briefs, and scientific studies based on cross-country analyses. PPRI conferences offer an opportunity for disseminating scientific output and engaging with stakeholders.
Conclusion:
PPRI is a network that has proven its value to policymakers by fostering information exchange as well as by producing reliable and relevant evidence. Success factors identified include a robust governance structure with clear responsibilities, a dedicated Secretariat as a coordinating function and the safe-space character of the network for its members.
Related Concept Videos
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
Drug Control Governance: Regulatory Bodies and Their Impact
Analysis of Population Pharmacokinetic Data
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Healthcare Agencies II
Parish nursing is a growing specialty nursing profession that focuses on holistic healthcare, health promotion, and illness prevention. It blends professional nursing practice with a health ministry, focusing on health and healing within the context of a Christian community. Parish nurses serve as health educators, referral sources, and lay...
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...

